Financial Architects (New Jersey)’s ANI Pharmaceuticals ANIP Stock Holding History

Financial Architects (New Jersey)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-75	Closed	-$4K	–	1478
2017 Q3	$4K	Hold	75	–	–	﹤0.01%	1297
2017 Q2	$4K	Sell	75 -200	-73%	-$9.65K	﹤0.01%	1317
2017 Q1	$14K	Hold	275	–	–	﹤0.01%	1040
2016 Q4	$17K	Hold	275	–	–	﹤0.01%	869
2016 Q3	$18K	Hold	275	–	–	﹤0.01%	863
2016 Q2	$15K	Hold	275	–	–	﹤0.01%	859
2016 Q1	$9K	Buy	+275	New	+$9.33K	﹤0.01%	767
2015 Q3	–	Sell	-275	Closed	-$17K	–	246
2015 Q2	$17K	Buy	275 +200	+267%	+$11.9K	0.01%	670
2015 Q1	$5K	Hold	75	–	–	﹤0.01%	866
2014 Q4	$4K	Buy	+75	New	+$3.31K	﹤0.01%	854

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Financial Architects (New Jersey)'s ANIP Position: Q4 2017 in Review

Financial Architects (New Jersey) sold out of ANI Pharmaceuticals (ANIP) in Q4 2017, closing a stake of 75 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in ANIP in Q4 2014 and held it in 10 quarters. The position peaked at $18K in Q3 2016. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

Financial Architects (New Jersey) reported no remaining ANI Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 75 ANI Pharmaceuticals shares in Q4 2017, an estimated $4K.
Financial Architects (New Jersey) first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 10 quarters.
Financial Architects (New Jersey)'s ANI Pharmaceuticals position peaked at $18K in Q3 2016.
163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2017, filed 12 Feb 2018.